Remy Peptides · For in-vitro laboratory research only. Not for human or veterinary use.Research Use Only
30mg total 300 clicks 0.1mg per click 60-click max dial For Research Use Only
TL;DR — Verdict

The 30mg retatrutide pen is a prefilled, multi-dose device: 30mg total, 300 clicks, 0.1mg per click, and a 60-click / 6mg maximum dial per injection. Use runs in six steps — room-temperature equilibration, a fresh needle, a 2-click prime, dialling the required clicks, subcutaneous delivery with a ~10-second hold, then needle removal and refrigerated storage — each walked through below, alongside specs, storage, and needle fit. For exact dose conversions, use the pen clicks chart. For pen-duration and pen-count math, use the retatrutide pen how many clicks calculator. For the TRIUMPH titration schedule, use the dosage guide. For the full molecule route through trials, approval status, dosing, and Dubai availability, use the retatrutide research hub. For research-use availability, batch proof, and formats in the UAE, see Retatrutide UAE formats.

Scope note: this guide covers the device itself. For exact mg-to-click lookup use the retatrutide pen clicks guide; for pen-count and duration math use the calculator.

How the Retatrutide Pen Works

A retatrutide pen is a prefilled, multi-dose subcutaneous delivery device holding retatrutide in a ready-to-use liquid formulation.[6] Unlike a lyophilised vial that must be reconstituted with bacteriostatic water before each use, the pen ships pre-loaded and uses a click-based dial mechanism for precise dose selection. Each click of the dial dispenses exactly 0.1mg of retatrutide — mechanical, repeatable, and independent of syringe markings.

This guide covers how to use the pen end to end: the hardware (30mg total, 300 clicks, 0.1mg per click), priming, the injection sequence, storage, and which needles fit. For the regulatory picture see the approval page; for the week-by-week TRIUMPH titration schedule see the dosage guide; and for the exact mg-to-click lookup table see the clicks guide.

The pen format suits research protocols that demand repeated, precisely metered doses across multi-week titration schedules. The dial supports stepwise escalation and protocol-defined adjustments mirroring the dose arms used across published Phase 2 and Phase 3 retatrutide trials.[1][3] If you need the weekly titration schedule, use the dosage guide. For direct mg-to-click conversion, use the clicks chart. For pen-count and protocol-length planning, use the calculator.

What Are the Pen Specifications?

The retatrutide 30mg pen is a prefilled multi-dose device, with retatrutide solution delivered through the pen format. The nine spec rows below cover everything you need before reaching for the pen clicks guide or calculator.

Specification Detail
Format Prefilled Pen
Total Content 30mg retatrutide
Total Clicks 300 clicks
Dose per Click 0.1mg
Maximum Single Dose 60 clicks (6mg)
Administration Subcutaneous injection
Needle Compatibility Standard pen dispensing needles (30G/31G, 4–8mm)
Storage (unopened) 2–8°C (refrigerated)
Storage (in use) Refrigerated (2–8°C) — return after each use

The 60-click cap per injection is a mechanical limit of the dial — it physically stops at 60. Targets above 6mg are split across separate injections; for the exact split-dose lookup table, use the retatrutide pen clicks guide. The TRIUMPH Phase 3 program titrates retatrutide stepwise up to a 12mg weekly target dose, and the full escalation schedule lives in the dosage guide.[3]

How Do You Use a Retatrutide Pen?

Six steps cover the full cycle, from taking the pen out of the fridge to storing it again. Once the pen has reached room temperature the whole sequence takes about five minutes. The steps below describe how the device operates, for research handling and documentation — Remy Peptides products are supplied for in-vitro laboratory research only, not human or veterinary use.

Step 1 — Prepare

Take the pen out of the refrigerator 15–30 minutes before use so it reaches room temperature — equilibration does not change the formulation. Inspect the cartridge through the viewing window — the solution should be clear and colourless, with no particles or cloudiness. Set the pen aside if the contents are discoloured, particulate, or have been frozen.

Step 2 — Attach the Needle

Peel the paper seal from a fresh single-use pen needle, then screw or push it straight onto the pen tip until it is secure. Remove the outer cap (keep it for disposal) and the inner cap. Use a new needle for every injection — reused needles dull, can contaminate the solution, and risk leakage. The pen takes standard 30G/31G pen needles; the full needle-compatibility table is further down.

Step 3 — Prime

Priming a reta pen clears air from the cartridge and confirms the dial-to-needle path is open. Dial 2 clicks (0.2mg), hold the pen with the needle pointing up, tap the cartridge to move any air bubbles to the top, then press the plunger until a drop appears at the needle tip. If no drop appears, repeat. Prime every time you fit a new needle.

Step 4 — Dial the Dose

Turn the dial to the required number of clicks — each click is 0.1mg. The dial moves both ways, so an over-dial corrects back without wasting solution, and the mechanical cap is 60 clicks (6mg) per injection. The TRIUMPH Phase 3 program titrates retatrutide stepwise up to a 12mg weekly target.[3] For the week-by-week schedule use the dosage guide, for mg-to-click lookup use the pen clicks guide, and for pen-count math use the calculator.

Step 5 — Subcutaneous Injection

In the published trial programs, retatrutide was administered as a once-weekly subcutaneous injection.[1] On the pen, delivery is perpendicular (90°): the plunger is pressed fully until the pen clicks to confirm the dose is complete, then held in place for about 10 seconds before withdrawal so the full dose clears the cartridge.[6] The 10-second hold is what prevents leakage at the needle tip. Across the published Phase 2 and Phase 3 retatrutide trials, the most frequently reported adverse events were gastrointestinal — nausea, vomiting, diarrhoea, and constipation — and tended to be dose-dependent;[1] the tolerability data is summarised in the retatrutide profile.

Step 6 — Remove the Needle & Store

Twist or pull the used needle off the pen and drop it straight into a sharps container. Replace the cap and return the pen straight to refrigerated storage at 2–8°C — do not leave it at room temperature.

When Should You Use the Clicks Guide or Calculator?

This page is the device reference for pen format, storage, compatibility, and click-limit context, while the linked resources handle dose math and schedule planning. Three sibling pages handle the rest:

Pen vs Lyophilised Vial — Which Format?

Retatrutide is available in two delivery formats: prefilled pens (10mg entry pen, 20mg pen, 30mg flagship pen, 40mg high-load pen) and lyophilised powder vials (10mg vial, 40mg vial). The trade-offs in the retatrutide pen vs vial choice cluster around accuracy, convenience, contamination risk, and cost per milligram — the same format comparison researchers run across GLP-1 and multi-agonist research compounds.

Factor Prefilled Pen Lyophilised Vial
Preparation Ready to use — no mixing Requires reconstitution with bacteriostatic water
Dosing Accuracy 0.1mg per click — mechanical precision Depends on syringe volume markings
Contamination Risk Low — sealed cartridge, no open transfer Higher — multi-step reconstitution introduces contamination vectors
Convenience High — dial, dispense, store Low — requires vials, syringes, BAC water, mixing
Portability Compact, self-contained Requires carrying separate supplies
Cost per mg Higher upfront cost Typically lower per mg
Shelf Life (unopened) Refrigerated, manufacturer specified Longer — lyophilised powder is more stable
Skill Required Minimal — no reconstitution knowledge needed Moderate — must understand reconstitution ratios

For most research protocols, the pen format offers the best balance of accuracy, convenience, and contamination control. The vial format may be preferred when cost per milligram is the primary consideration or when researchers need to prepare custom concentrations, including cases where the protocol calls for mixing with a sterile diluent before dispensing. For a broader comparison of retatrutide against other compounds, see our retatrutide vs tirzepatide comparison.

How Should a Retatrutide Pen Be Stored?

Knowing how to store a retatrutide pen protects peptide integrity and keeps research results consistent. Retatrutide degrades when exposed to heat, light, or repeated freeze-thaw cycles, so the cold chain matters from delivery onward.

Before First Use

After First Use

So what happens if a retatrutide pen gets warm? Brief room-temperature exposure during use is expected, but sustained heat above 30°C or direct sun accelerates degradation — a pen left in a hot car or shipped without a cold chain should be treated as compromised. For underlying peptide degradation kinetics, see the peptide stability and storage guide. In hot climates such as the UAE — where ambient temperatures regularly exceed 45°C — temperature-controlled transport and refrigerated storage are non-negotiable. The Retatrutide UAE supply page covers the cold-chain logistics we use for Dubai-based research orders, and the broader UAE peptide catalog lists every research compound currently in stock.

What Needles Are Compatible?

Needles for the retatrutide pen are standard screw-on pen needles — the same universal fitting used by most prefilled pen injectors. Pen needles are sold separately and should be single-use only.

Needle Spec Recommended Notes
Gauge 30G or 31G Smaller outer diameter
Length 4mm or 5mm Common length for subcutaneous delivery devices
Alternative Length 6mm or 8mm Protocol-dependent alternative
Brands BD Micro-Fine, NovoFine, Owen Mumford Any standard pen needle with universal screw-on fitting

Key needle rules: Always use a new needle for each injection. Never leave a needle attached to the pen between uses — this can cause air entry, contamination, and solution leakage. Dispose of used needles in a proper sharps container immediately after use.

How do you use a retatrutide pen?
The documented sequence is: room-temperature equilibration with a clarity check, a fresh 30G or 31G needle, a 2-click prime until a drop appears at the tip, dialling the required clicks (each click is 0.1mg), subcutaneous delivery at 90° held for about 10 seconds, then needle removal and 2–8°C storage. The full six-step walkthrough is above.
How do you prime a retatrutide pen?
Dial 2 clicks (0.2mg), hold the pen with the needle pointing up, tap the cartridge to move air to the top, then press the plunger until a drop appears at the needle tip. Prime each time you fit a new needle; if no drop appears, repeat.
What does the 30mg retatrutide pen contain?
The 30mg retatrutide pen holds 30mg total — 300 clicks at 0.1mg per click, with a 60-click (6mg) maximum dial per injection.
What is the maximum single setting on the retatrutide pen?
The dial physically stops at 60 clicks, which equals 6mg per injection. Protocol targets above 6mg are modelled as separate injections — see the retatrutide pen clicks guide for the split-dose lookup table.
How should a retatrutide pen be stored, and what happens if it gets warm?
Store pens refrigerated at 2–8°C at all times — before and after first use — and never freeze them. Allow brief equilibration to room temperature during use only, then return the pen to the fridge; do not store it at room temperature. Heat above 30°C or direct sunlight accelerates peptide degradation, so a pen left in a hot car or shipped without a cold chain should be treated as compromised. See the peptide stability and storage guide for the kinetics.
What needles are compatible with a retatrutide pen?
Standard screw-on pen needles in 30G or 31G gauge, 4–8mm length (4–5mm suits most subcutaneous work). Brands such as BD Micro-Fine, NovoFine, and Owen Mumford fit. Needles are single-use — attach a fresh one for every injection and remove it before storage.
Where do I check exact click conversions or pen-duration math?
Use the retatrutide pen clicks guide for exact mg-to-click lookup, and the calculator for pen-duration or pen-count math across a multi-week protocol.

Our Research Standards

This article cites peer-reviewed studies, FDA filings, and ClinicalTrials.gov data. All claims are cross-referenced against primary sources. We update articles when new trial data or regulatory decisions are published. Read our editorial policy →

RP
Editorial Review

Editorial Board, Remy Peptides

The Remy Peptides Editorial Board reviews research articles covering GLP-1 receptor agonists, triple agonists, and the obesity drug pipeline. Its review spans peptide analytical chemistry, HPLC purity validation, and clinical trial data interpretation.

About the editorial team →

Sources

  1. Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514–526. nejm.org
  2. Janoshik Analytical — Certificate of Analysis, Batch RETP002. HPLC purity: 99.262%. remypeptides.com/coa
  3. Eli Lilly. TRIUMPH Clinical Trial Program for Retatrutide. clinicaltrials.gov
  4. Rosenstock J, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-comparator-controlled, parallel-group, phase 2 trial. Lancet. 2023;402(10401):529–544.
  5. Frias JP, et al. Efficacy and safety of LY-3437943, a novel triple GIP/GLP-1/glucagon receptor agonist in patients with type 2 diabetes. Lancet. 2022;400(10366):1869–1881.
  6. USP General Chapter <1>. Injections and Implanted Drug Products. United States Pharmacopeia.
Retatrutide 30mg Pen — AED 1,600 Research use only
Order